QuestionSBA
QuestionChoice
DPP-4 inhibitors are considered a 2nd line treatment option for type 2 diabetes. Known side effects of this group include hypoglycaemia and nausea. They are not as closely linked to genital mycotic infections as SGLT-2 inhibitors, making this answer incorrect.
10025614
e
Sitagliptin (DPP-4 inhibitor)
QuestionChoice
SGLT-2 inhibitors are prescribed 1st line for type 2 diabetes if individuals have risk factors for cardiovascular disease. They are associated with a predisposition to developing fungal infections, particularly genital mycotic infections as seen in this case.
10025610
a
Dapagliflozin (SGLT-2 inhibitor)
QuestionChoice
Metformin is typically prescribed as 1st line in type 2 diabetes. Known side effects include gastrointestinal upset and more rarely, lactic acidosis. Metformin can be prescribed as a modified-release version to overcome gastrointestinal upset side effects. It is not as closely linked to genital mycotic infections as SGLT-2 inhibitors, making this answer incorrect.
10025613
d
Metformin (Biguanide)
QuestionChoice
Thiazolidinediones are typically 2nd line options for type 2 diabetes, after metformin and SGLT-2 inhibitors. Known side effects of this drug group include oedema and weight gain. They are not as closely linked to genital mycotic infections as SGLT-2 inhibitors, making this answer incorrect.
10025612
c
Pioglitazone (thiazolidinedione)
QuestionChoice
Sulphonylureas are typically a 2nd line option for type 2 diabetes, after metformin and SGLT-2 inhibitors. They can be used 1st line for steroid-induced hyperglycaemia. Known side effects of this group include hypoglycaemia and weight gain. They are not as closely linked to genital mycotic infections as SGLT-2 inhibitors, making this answer incorrect.
10025611
b
Gliclazide (sulphonylurea)
Concept
Chapter
2693
5789
SGLT-2 inhibitors
Topic
220
Endocrine Pharmacology
17520
A 53 year old man attends his GP surgery with concerns about soreness and itching around his penis. The GP diagnoses a genital mycotic infection. The patient has a history of type 2 diabetes, for which he takes medication.

Which of the following diabetic medications is most likely to have contributed to this patient's symptoms?
a